Myxedema coma: Recognition and treatment
- PMID: 35752902
- DOI: 10.1097/01.NURSE.0000832344.83659.a4
Myxedema coma: Recognition and treatment
Abstract
Myxedema coma (MC) develops from a long-standing, unrecognized, or untreated hypothyroidism. This article discusses the pathophysiology, clinical manifestations, treatment, and nursing considerations for patients with MC.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Pagana D, Pagana T, Pagana T. Mosby Manual of Diagnostic and Laboratory Tests . 7th ed. Maryland Heights, MO: Elsevier; 2022.
-
- Hardin MM, Kwong J, Roberts D, Kwong J, Hagler D, Reinish C. Lewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems . 11th ed. Maryland Heights, MO: Elsevier; 2022.
-
- Golan DE, Armstrong EJ, Armstrong AW. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy: Fourth Edition . Philadelphia, PA: Wolters Kluwer Health; 2005.
-
- Rizzo LFL, Mana DL, Bruno OD, Wartofsky L. Myxedema coma. Medicina (B Aires) . 2017;77(4):321–328.
-
- Spitzweg C, Reincke M, Gärtner R. Thyroid emergencies: thyroid storm and myxedema coma. Internist (Berl) . 2017;58(10):1011–1019. doi:10.1007/s00108-017-0306-0.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical